In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.
Scientists studied blood samples from 300 patients with septicemia, examining how different MRSA strains behave and assessing their lethality.
Scientists from The Wellcome Trust Sanger Institute, Public Health England, and elsewhere sequenced the genomes of 209 MRSA isolates collected in Europe from 1960 to 1989.
The financing will go toward efforts by the German firm to bring its point-of-care screening system for drug-resistant bacteria to hospitals.
The test, which simultaneously detects MRSA and Staphylococcus aureus, is designed to run on the company's Liat PCR point-of-care platform.
To develop the test, the firm said it used a library of MRSA strains collected around the world, and included components that reduce false positive results.
In Genome Biology this week: over-representation of European individuals in large datasets, methicillin-resistant Staphylococcus aureus clone in East Asia, and more.
The company attributed the increase in revenue to a $700,000 increase in product sales, particularly its rapid pathogen ID molecular diagnostic.
Researchers examined virulence, resistance, and transmission patterns in genome sequence data for more than 300 invasive Staphylococcus aureus isolates from Europe.
The upgraded test includes new gene targets for methicillin resistance, and provides room-temperature storage and validation on multiple swab types.
Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.
University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.
The Wall Street Journal examines billing codes used by uBiome.
In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.